These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1281940)

  • 61. Protection from chlordecone-amplified carbon tetrachloride toxicity by cyanidanol: biochemical and histological studies.
    Soni MG; Mehendale HM
    Toxicol Appl Pharmacol; 1991 Mar; 108(1):46-57. PubMed ID: 1706539
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of chlordecone on food intake and body weight in the male rat.
    Williams J; Montanez S; Uphouse L
    Neurotoxicology; 1992; 13(2):453-62. PubMed ID: 1279491
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Kepone--hazard evaluation.
    Epstein SS
    Sci Total Environ; 1978 Jan; 9(1):1-62. PubMed ID: 74851
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Chlordecone exposure and risk of prostate cancer.
    Multigner L; Ndong JR; Giusti A; Romana M; Delacroix-Maillard H; Cordier S; Jégou B; Thome JP; Blanchet P
    J Clin Oncol; 2010 Jul; 28(21):3457-62. PubMed ID: 20566993
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Evaluation of the ecotoxicological impact of the organochlorine chlordecone on soil microbial community structure, abundance, and function.
    Merlin C; Devers M; Béguet J; Boggio B; Rouard N; Martin-Laurent F
    Environ Sci Pollut Res Int; 2016 Mar; 23(5):4185-98. PubMed ID: 26025175
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Kepone in James River fish: 1976-2002.
    Luellen DR; Vadas GG; Unger MA
    Sci Total Environ; 2006 Apr; 358(1-3):286-97. PubMed ID: 16256173
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Studies on the mechanism of chlordecone-induced tremor in rats.
    Gerhart JM; Hong JS; Tilson HA
    Neurotoxicology; 1985; 6(1):211-29. PubMed ID: 2581196
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Chlordecone toxicity: effect of withdrawal of treatment on ATPase inhibition.
    Bansal SK; Desaiah D
    Neurotoxicology; 1985; 6(3):103-7. PubMed ID: 2413407
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Carcinogenicity of kepone.
    Reuber MD
    J Toxicol Environ Health; 1978; 4(5-6):895-911. PubMed ID: 83367
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Chlordecone: development of a physiologically based pharmacokinetic tool to support human health risks assessments.
    Emond C; Multigner L
    Arch Toxicol; 2022 Apr; 96(4):1009-1019. PubMed ID: 35122515
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hypothalamic-pituitary adrenal (HPAA) axis function in adult Fischer-344 rats exposed during development to neurotoxic chemicals perinatally.
    Rosecrans JA; Johnson JH; Tilson HA; Hong JS
    Neurobehav Toxicol Teratol; 1984; 6(4):281-8. PubMed ID: 6083462
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Functional and biochemical correlates of chlordecone exposure and its enhancement of CCl4 hepatotoxicity.
    Davis ME; Mehendale HM
    Toxicology; 1980; 15(2):91-103. PubMed ID: 6154986
    [TBL] [Abstract][Full Text] [Related]  

  • 73. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Toxicology and carcinogenesis studies of a binary mixture of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) and 2,3',4,4',5-pentachlorobiphenyl (PCB 118) (Cas No. 31508-00-6) in female Harlan Sprague-Dawley rats (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Nov; (531):1-218. PubMed ID: 17342196
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Systematic review of the impact of chlordecone on human health in the French West Indies].
    Maudouit M; Rochoy M
    Therapie; 2019 Dec; 74(6):611-625. PubMed ID: 31088689
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of chlordecone administration on brain and pituitary peptide systems.
    Hong JS; Hudson PM; Yoshikawa K; Ali SF; Mason GA
    Neurotoxicology; 1985; 6(1):167-82. PubMed ID: 2581193
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Utilizing relative potency factors (RPF) and threshold of toxicological concern (TTC) concepts to assess hazard and human risk assessment profiles of environmental metabolites: a case study.
    Terry C; Rasoulpour RJ; Knowles S; Billington R
    Regul Toxicol Pharmacol; 2015 Mar; 71(2):301-17. PubMed ID: 25584438
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of perinatal exposure to chlordecone (Kepone) on neuroendocrine and neurochemical responsiveness of rats to environmental challenges.
    Rosecrans JA; Hong JS; Squibb RE; Johnson JH; Wilson WE; Tilson HA
    Neurotoxicology; 1982 Oct; 3(2):131-42. PubMed ID: 6186958
    [No Abstract]   [Full Text] [Related]  

  • 79. NTP Toxicology and Carcinogenesis Studies of Dimethylvinyl Chloride (1-Chloro-2-Methylpropene) (CAS No. 513-37-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1986 Aug; 316():1-238. PubMed ID: 12748737
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Characterization and quantification of chlordecone elimination in ewes.
    Saint-Hilaire M; Fourcot A; Bousquet-Mélou A; Rychen G; Thomé JP; Parinet J; Feidt C; Fournier A
    Environ Toxicol Pharmacol; 2021 Oct; 87():103698. PubMed ID: 34224866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.